Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orasis Prepares To Battle AbbVie In Presbyopia

Qlosi Clears US FDA

Oct 19 2023

• By Joseph Haas

eye%20drops.jpg — Orasis's Qlosi will compete directly against AbbVie's Vuity

Related Content

With Vuity Approval, AbbVie Continues Stepping Into Eye Care

Nov 03 2021

Deal Watch: Visus Begins Charting Its Direction In Ophthalmology With Two Deals

Aug 20 2021

Finance Watch: $320m In New VC Deals Includes $110m Round For Neogene

Sep 15 2020

Related Companies

AbbVie Inc.

Orasis Pharmaceuticals Ltd.

Visus Therapeutics, Inc.

Hyperion DeFi, Inc.

Opus Genetics, Inc

ReVision Optics, Inc.

Additional Topics

Approvals Business Strategies Commercial Ophthalmic BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window